$ALTH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALLOS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALLOS THERAPEUTICS INC. Get notifications about new insider transactions in ALLOS THERAPEUTICS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 10 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | LEFF JONATHAN S | Director | Option Exercise | A | 2.46 | 20,000 | 49,200 | 20,000 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | LEFF JONATHAN S | Director | Option Exercise | C | 0.00 | 2,262,443 | 0 | 0 | |
May 20 2005 | ALTH | ALLOS THERAPEUTICS ... | LEFF JONATHAN S | Director | Buy | C | 0.00 | 22,624,430 | 0 | 22,624,430 | 0 to 22.6 M |
Mar 08 2005 | ALTH | ALLOS THERAPEUTICS ... | Saunders Michael E | VP, Clinical Develo ... | Option Exercise | A | 2.46 | 20,000 | 49,200 | 20,000 | |
Mar 08 2005 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | A | 2.46 | 35,000 | 86,100 | 35,000 | |
Mar 08 2005 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Option Exercise | A | 2.46 | 17,000 | 41,820 | 17,000 | |
Mar 08 2005 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Controller | Option Exercise | A | 2.46 | 15,000 | 36,900 | 15,000 | |
Mar 08 2005 | ALTH | ALLOS THERAPEUTICS ... | DELONG DAVID A | Vice President, Sal ... | Option Exercise | A | 2.46 | 20,000 | 49,200 | 20,000 | |
Mar 08 2005 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | A | 2.46 | 20,000 | 49,200 | 20,000 | |
Feb 09 2005 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Chief Executive Off ... | Option Exercise | A | 2.37 | 40,000 | 94,800 | 40,000 | |
Jan 04 2005 | ALTH | ALLOS THERAPEUTICS ... | Saunders Michael E | VP, Clinical Develo ... | Buy | P | 1.85 | 2,500 | 4,633 | 2,500 | 0 to 2.5 K |
Jan 04 2005 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | P | 1.85 | 2,165 | 4,012 | 9,039 | 6.9 K to 9 K (+31.50 %) |
Jan 04 2005 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Buy | P | 1.85 | 1,298 | 2,405 | 4,885 | 3.6 K to 4.9 K (+36.19 %) |
Jan 04 2005 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Controller | Buy | P | 1.85 | 985 | 1,825 | 985 | 0 to 985 |
Oct 13 2004 | ALTH | ALLOS THERAPEUTICS ... | Graboyes Marc H | VP, General Counsel | Option Exercise | A | 2.00 | 80,000 | 160,000 | 80,000 | |
Sep 10 2004 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Option Exercise | A | 2.28 | 8,675 | 19,779 | 10,000 | |
Sep 10 2004 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Option Exercise | A | 2.28 | 1,325 | 3,021 | 1,325 | |
Sep 10 2004 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | A | 2.28 | 15,000 | 34,200 | 15,000 | |
Sep 10 2004 | ALTH | ALLOS THERAPEUTICS ... | Clark David C | Controller | Option Exercise | A | 2.28 | 10,000 | 22,800 | 10,000 | |
Aug 31 2004 | ALTH | ALLOS THERAPEUTICS ... | ABRAHAM DONALD J | Option Exercise | H | 7.20 | 10,000 | 72,000 | 0 | ||
Aug 31 2004 | ALTH | ALLOS THERAPEUTICS ... | ABRAHAM DONALD J | Option Exercise | H | 6.73 | 10,000 | 67,300 | 0 | ||
Aug 31 2004 | ALTH | ALLOS THERAPEUTICS ... | ABRAHAM DONALD J | Option Exercise | H | 3.30 | 10,000 | 33,000 | 0 | ||
Aug 13 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | Sell | S | 1.95 | 1,455 | 2,837 | 0 | 1.5 K to 0 (-100.00 %) | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 6.00 | 7,976 | 47,856 | 0 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 5.44 | 26,375 | 143,480 | 0 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 4.75 | 27,617 | 131,181 | 0 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 4.75 | 10,063 | 47,799 | 27,617 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 4.52 | 70,561 | 318,936 | 0 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 4.52 | 4,439 | 20,064 | 70,561 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 3.20 | 28,185 | 90,192 | 0 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 3.20 | 1,815 | 5,808 | 28,185 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 2.82 | 57,094 | 161,005 | 0 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | H | 2.82 | 42,906 | 120,995 | 57,094 | |
Aug 10 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 1.78 | 50,000 | 89,000 | 50,000 | |
Jul 02 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Buy | P | 1.91 | 1,455 | 2,783 | 1,455 | 0 to 1.5 K |
Jul 02 2004 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Buy | P | 1.91 | 1,156 | 2,211 | 3,587 | 2.4 K to 3.6 K (+47.55 %) |
Jul 02 2004 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Buy | P | 1.91 | 1,042 | 1,993 | 6,874 | 5.8 K to 6.9 K (+17.87 %) |
Jun 16 2004 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Chief Executive Off ... | Option Exercise | A | 2.29 | 7,501 | 17,177 | 40,000 | |
Jun 16 2004 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Chief Executive Off ... | Option Exercise | A | 2.29 | 12,499 | 28,623 | 32,499 | |
Jun 16 2004 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Chief Executive Off ... | Option Exercise | A | 2.29 | 8,658 | 19,827 | 20,000 | |
Jun 16 2004 | ALTH | ALLOS THERAPEUTICS ... | HART MICHAEL E | Chief Executive Off ... | Option Exercise | A | 2.29 | 11,342 | 25,973 | 11,342 | |
Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | DELONG DAVID A | Vice President, Sal ... | Option Exercise | A | 2.82 | 36,944 | 104,182 | 75,000 | |
Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | DELONG DAVID A | Vice President, Sal ... | Option Exercise | A | 2.82 | 38,056 | 107,318 | 38,056 | |
Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 2.82 | 57,094 | 161,005 | 100,000 | |
Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 2.82 | 42,906 | 120,995 | 42,906 | |
Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 2.82 | 57,094 | 161,005 | 100,000 | |
Jun 04 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 2.82 | 42,906 | 120,995 | 42,906 | |
May 18 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Sell | S | 2.03 | 1,045 | 2,121 | 0 | 1 K to 0 (-100.00 %) |
May 18 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Sell | S | 2.03 | 1,159 | 2,353 | 1,045 | 2.2 K to 1 K (-52.59 %) |
May 13 2004 | ALTH | ALLOS THERAPEUTICS ... | CASEY MICHAEL D | Director | Option Exercise | A | 2.12 | 10,000 | 21,200 | 10,000 | |
May 13 2004 | ALTH | ALLOS THERAPEUTICS ... | EDWARDS MARK G | Director | Option Exercise | A | 2.12 | 10,000 | 21,200 | 10,000 | |
May 13 2004 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Option Exercise | A | 2.12 | 10,000 | 21,200 | 10,000 | |
May 13 2004 | ALTH | ALLOS THERAPEUTICS ... | JAFFE MARVIN | Director | Option Exercise | A | 2.12 | 10,000 | 21,200 | 10,000 | |
Apr 29 2004 | ALTH | ALLOS THERAPEUTICS ... | PEARL FRANK H | 10% Owner | Sell | S | 4.90 | 472,700 | 2,316,230 | 2,295,400 | 2.8 M to 2.3 M (-17.08 %) |
Apr 29 2004 | ALTH | ALLOS THERAPEUTICS ... | PEARL FRANK H | 10% Owner | Sell | S | 4.85 | 25,000 | 121,250 | 2,768,100 | 2.8 M to 2.8 M (-0.90 %) |
Apr 29 2004 | ALTH | ALLOS THERAPEUTICS ... | PEARL FRANK H | 10% Owner | Sell | S | 4.90 | 67,000 | 328,300 | 2,793,100 | 2.9 M to 2.8 M (-2.34 %) |
Apr 29 2004 | ALTH | ALLOS THERAPEUTICS ... | PEARL FRANK H | 10% Owner | Sell | S | 5.00 | 300,000 | 1,500,000 | 2,860,100 | 3.2 M to 2.9 M (-9.49 %) |
Mar 25 2004 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Sell | S | 4.87 | 300 | 1,461 | 0 | 300 to 0 (-100.00 %) |
Mar 25 2004 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Sell | S | 4.87 | 300 | 1,461 | 0 | 300 to 0 (-100.00 %) |
Mar 23 2004 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Grant | A | 18.00 | 100 | 1,800 | 100 | 0 to 100 |
Mar 23 2004 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Grant | A | 18.00 | 100 | 1,800 | 100 | 0 to 100 |
Mar 23 2004 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Grant | A | 18.00 | 100 | 1,800 | 100 | 0 to 100 |
Mar 23 2004 | ALTH | ALLOS THERAPEUTICS ... | HOFFMAN STEPHEN J | Chariman of the Boa ... | Grant | A | 18.00 | 100 | 1,800 | 100 | 0 to 100 |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Option Exercise | M | 3.20 | 5,625 | 18,000 | 9,375 | |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Option Exercise | M | 2.42 | 5,208 | 12,603 | 0 | |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Option Exercise | M | 2.42 | 10,416 | 25,207 | 5,208 | |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Option Exercise | M | 0.56 | 1,984 | 1,111 | 0 | |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Option Exercise | M | 0.40 | 1,200 | 480 | 0 | |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Sell | S | 5.35 | 5,625 | 30,094 | 55 | 5.7 K to 55 (-99.03 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Buy | M | 3.20 | 5,625 | 18,000 | 5,680 | 55 to 5.7 K (+10,227.27 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Sell | S | 5.35 | 5,208 | 27,863 | 55 | 5.3 K to 55 (-98.95 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Buy | M | 2.42 | 5,208 | 12,603 | 5,263 | 55 to 5.3 K (+9,469.09 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Sell | S | 5.35 | 10,416 | 55,726 | 55 | 10.5 K to 55 (-99.47 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Buy | M | 2.42 | 10,416 | 25,207 | 10,471 | 55 to 10.5 K (+18,938.18 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Sell | S | 5.35 | 1,984 | 10,614 | 55 | 2 K to 55 (-97.30 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Buy | M | 0.56 | 1,984 | 1,111 | 2,039 | 55 to 2 K (+3,607.27 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Sell | S | 5.35 | 1,200 | 6,420 | 55 | 1.3 K to 55 (-95.62 %) |
Mar 18 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Buy | M | 0.40 | 1,200 | 480 | 1,255 | 55 to 1.3 K (+2,181.82 %) |
Mar 05 2004 | ALTH | ALLOS THERAPEUTICS ... | PEARL FRANK H | 10% Owner | Sell | S | 5.50 | 80,000 | 440,000 | 2,820,100 | 2.9 M to 2.8 M (-2.76 %) |
Mar 05 2004 | ALTH | ALLOS THERAPEUTICS ... | PEARL FRANK H | 10% Owner | Sell | S | 5.51 | 35,000 | 192,850 | 2,900,100 | 2.9 M to 2.9 M (-1.19 %) |
Mar 05 2004 | ALTH | ALLOS THERAPEUTICS ... | PEARL FRANK H | 10% Owner | Sell | S | 5.31 | 225,000 | 1,194,750 | 2,935,100 | 3.2 M to 2.9 M (-7.12 %) |
Mar 02 2004 | ALTH | ALLOS THERAPEUTICS ... | JOHNSON DOUGLAS G | VP of Manufacturing | Option Exercise | A | 5.44 | 12,560 | 68,326 | 12,560 | |
Mar 02 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 5.44 | 26,375 | 143,480 | 26,375 | |
Mar 02 2004 | ALTH | ALLOS THERAPEUTICS ... | CAGNONI PABLO J | VP of Clinical Affa ... | Option Exercise | A | 5.44 | 26,375 | 143,480 | 26,375 | |
Mar 02 2004 | ALTH | ALLOS THERAPEUTICS ... | WILSON PAULETTE M | Controller | Option Exercise | A | 5.44 | 7,965 | 43,330 | 7,965 | |
Mar 02 2004 | ALTH | ALLOS THERAPEUTICS ... | HERZIG MARKUS F | VP Regulatory Affai ... | Option Exercise | A | 5.44 | 12,560 | 68,326 | 12,560 | |
Mar 02 2004 | ALTH | ALLOS THERAPEUTICS ... | DELONG DAVID A | Vice President, Sal ... | Option Exercise | A | 5.44 | 17,584 | 95,657 | 17,584 | |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.47 | 50,000 | 123,320 | 2,710,000 | 2.8 M to 2.7 M (-1.81 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.47 | 200,000 | 493,280 | 2,760,000 | 3 M to 2.8 M (-6.76 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.44 | 40,000 | 97,796 | 2,960,000 | 3 M to 3 M (-1.33 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.43 | 82,270 | 199,776 | 3,000,000 | 3.1 M to 3 M (-2.67 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.51 | 63,000 | 157,828 | 3,082,270 | 3.1 M to 3.1 M (-2.00 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 2.50 | 100 | 250 | 3,145,270 | 3.1 M to 3.1 M (0.00 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.52 | 99,400 | 250,756 | 3,145,170 | 3.2 M to 3.1 M (-3.06 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.54 | 25,000 | 63,455 | 3,244,570 | 3.3 M to 3.2 M (-0.76 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.78 | 54,100 | 150,479 | 3,269,570 | 3.3 M to 3.3 M (-1.63 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.78 | 74,630 | 207,158 | 3,323,670 | 3.4 M to 3.3 M (-2.20 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 2.81 | 1,000 | 2,805 | 3,398,300 | 3.4 M to 3.4 M (+0.03 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 2.81 | 1,000 | 2,805 | 3,397,300 | 3.4 M to 3.4 M (+0.03 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.98 | 33,700 | 100,278 | 3,396,300 | 3.4 M to 3.4 M (-0.98 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.97 | 2,600 | 7,721 | 3,430,000 | 3.4 M to 3.4 M (-0.08 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.98 | 72,500 | 215,905 | 3,432,600 | 3.5 M to 3.4 M (-2.07 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.91 | 102,800 | 298,768 | 3,505,100 | 3.6 M to 3.5 M (-2.85 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.78 | 52,100 | 144,770 | 3,607,900 | 3.7 M to 3.6 M (-1.42 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.79 | 107,934 | 301,503 | 3,660,000 | 3.8 M to 3.7 M (-2.86 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.78 | 70,000 | 194,586 | 3,767,934 | 3.8 M to 3.8 M (-1.82 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.93 | 54,300 | 159,137 | 3,837,934 | 3.9 M to 3.8 M (-1.40 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.92 | 57,766 | 168,873 | 3,892,234 | 4 M to 3.9 M (-1.46 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.88 | 150,000 | 431,325 | 3,950,000 | 4.1 M to 4 M (-3.66 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.94 | 67,300 | 197,707 | 4,100,000 | 4.2 M to 4.1 M (-1.61 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.77 | 100,000 | 277,060 | 4,167,300 | 4.3 M to 4.2 M (-2.34 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.73 | 44,000 | 120,309 | 4,267,300 | 4.3 M to 4.3 M (-1.02 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.82 | 43,000 | 121,243 | 4,311,300 | 4.4 M to 4.3 M (-0.99 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.72 | 65,000 | 176,599 | 4,354,300 | 4.4 M to 4.4 M (-1.47 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.61 | 20,700 | 54,027 | 4,419,300 | 4.4 M to 4.4 M (-0.47 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.60 | 60,000 | 156,084 | 4,440,000 | 4.5 M to 4.4 M (-1.33 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 3.03 | 45,000 | 136,305 | 4,500,000 | 4.5 M to 4.5 M (-0.99 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.41 | 21,000 | 50,696 | 2,452,000 | 2.5 M to 2.5 M (-0.85 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.41 | 150,000 | 362,115 | 2,473,000 | 2.6 M to 2.5 M (-5.72 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 2.46 | 87,000 | 213,907 | 2,623,000 | 2.7 M to 2.6 M (-3.21 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.86 | 85,000 | 158,151 | 5,194,300 | 5.3 M to 5.2 M (-1.61 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.86 | 12,800 | 23,853 | 5,279,300 | 5.3 M to 5.3 M (-0.24 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.86 | 5,400 | 10,025 | 5,292,100 | 5.3 M to 5.3 M (-0.10 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.87 | 40,000 | 74,832 | 5,297,500 | 5.3 M to 5.3 M (-0.75 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 1.98 | 1,000 | 1,975 | 5,337,500 | 5.3 M to 5.3 M (+0.02 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.85 | 19,800 | 36,719 | 5,336,500 | 5.4 M to 5.3 M (-0.37 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.88 | 17,400 | 32,658 | 5,356,300 | 5.4 M to 5.4 M (-0.32 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.89 | 60,000 | 113,124 | 5,373,700 | 5.4 M to 5.4 M (-1.10 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 1.92 | 3,000 | 5,769 | 5,433,700 | 5.4 M to 5.4 M (+0.06 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 2.00 | 30,700 | 61,277 | 5,430,700 | 5.4 M to 5.4 M (+0.57 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.84 | 25,000 | 46,053 | 5,400,000 | 5.4 M to 5.4 M (-0.46 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.79 | 75,000 | 134,085 | 5,425,000 | 5.5 M to 5.4 M (-1.36 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.88 | 91,575 | 171,740 | 5,500,000 | 5.6 M to 5.5 M (-1.64 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 1.89 | 147,100 | 277,754 | 5,391,575 | 5.5 M to 5.4 M (-2.66 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 2.54 | 31,100 | 79,062 | 5,738,675 | 5.7 M to 5.7 M (+0.54 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.44 | 5,000 | 17,178 | 5,707,575 | 5.7 M to 5.7 M (+0.09 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.29 | 1,000 | 3,293 | 5,702,575 | 5.7 M to 5.7 M (+0.02 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.25 | 3,700 | 12,031 | 5,701,575 | 5.7 M to 5.7 M (+0.06 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.25 | 2,700 | 8,779 | 5,697,875 | 5.7 M to 5.7 M (+0.05 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.28 | 1,500 | 4,913 | 5,695,175 | 5.7 M to 5.7 M (+0.03 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.22 | 24,100 | 77,638 | 5,693,675 | 5.7 M to 5.7 M (+0.43 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.39 | 3,700 | 12,539 | 5,669,575 | 5.7 M to 5.7 M (+0.07 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.42 | 38,600 | 131,935 | 5,665,875 | 5.6 M to 5.7 M (+0.69 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.23 | 12,300 | 39,730 | 5,632,275 | 5.6 M to 5.6 M (+0.22 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Sell | S | 3.34 | 35,100 | 117,311 | 5,619,975 | 5.7 M to 5.6 M (-0.62 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.39 | 50,500 | 171,256 | 5,655,075 | 5.6 M to 5.7 M (+0.90 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.32 | 7,500 | 24,900 | 5,604,575 | 5.6 M to 5.6 M (+0.13 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 3.81 | 62,900 | 239,687 | 5,597,075 | 5.5 M to 5.6 M (+1.14 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 4.23 | 10,000 | 42,349 | 5,534,175 | 5.5 M to 5.5 M (+0.18 %) |
Aug 22 2003 | ALTH | ALLOS THERAPEUTICS ... | DURUS CAPITAL MANAGEMENT | 10% Owner | Buy | P | 4.24 | 44,300 | 187,752 | 5,524,175 | 5.5 M to 5.5 M (+0.81 %) |